{"name":"GEN İlaç ve Sağlık Ürünleri A.Ş.","slug":"gen-i-la-ve-sa-l-k-r-nleri-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Clobetasol 17-propionate","genericName":"Clobetasol 17-propionate","slug":"clobetasol-17-propionate","indication":"Severe skin conditions such as psoriasis, atopic dermatitis, and seborrheic dermatitis","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"GN-037","genericName":"GN-037","slug":"gn-037","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Clobetasol 17-propionate","genericName":"Clobetasol 17-propionate","slug":"clobetasol-17-propionate","phase":"phase_2","mechanism":"Glucocorticoid receptor agonist","indications":["Severe skin conditions such as psoriasis, atopic dermatitis, and seborrheic dermatitis"],"catalyst":""},{"name":"GN-037","genericName":"GN-037","slug":"gn-037","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxPTmxVZVg2aldFYUlxeVdKX1BiSk52MmRIR0t4ZXlqeGJDc2hfRW9xVlJRdFhfd0ZMRWN2MFN0VTNBUk1Pc3JtRGIxOXBOczl4WVJXYVJPMTNyeDNwd1U1ZUpQX1huT3BYa094aFhnLVFuMVROVXVPVHVfSzc5a04zLVozUVExbm9nYTFQaDh0ZzVENlNVUEduTjQwSlMxbXRYNDJjT0IycWF5eUZzakU3M3NWRjZtczhMb1JJS3Q0OXQzMFdqakwxT1BaMm5RY1hBTHZUZVliWmFLUDNEdXVNbml0cDJ0WXd6YmRQVnVvSlVHZ1dMVzdFZ3ZMTzl4NjdTbm5V?oc=5","date":"2025-12-02","type":"trial","source":"BioSpace","summary":"GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases - BioSpace","headline":"GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegener","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxNekRNemItQnlEOE5BODZ5Xy1nZUQ2Q2RodU4zVHU3M2JHS0dTRzJTUlJfOXFMWldoXzNtUTcxTVphOEYwOVdqSWxrdi0tUVlPU1EzRUZaa3M1MmJ2bVdSR2RGUkxubjU2dkRBMUtHOUNSdFg0eG12ZUZmU2t5bUpDUXBVSHBSMWc1eXZna1AyTlVnMzlwek1PLW9tSDBSdzBuYkNEcVJXd0VJZ2puYnY1U0tHcGFYWTNwZWRfdHlEUEVGRUtGZHlFLXpid2dOLUpPbVVFTk9JalhGNHA0VEZnYzF4U2FJVDhTT3VMamFyY0FVMEI3MDM4ZmcwVlpMMU9WelUxSzlmaWlTdXpV?oc=5","date":"2025-07-29","type":"trial","source":"BioSpace","summary":"GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases - BioSpace","headline":"GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neuro","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFB3czVJZ2hkWkZVMjdWRlVlaUZ5NWJqelBLNHdQem44WmdyM0RvSmg0TWFncERnOW5zYzlvZXRzM25QQTZBNlIxaXlXa3NTMlRicktmRQ?oc=5","date":"2023-12-07","type":"trial","source":"AzerNews","summary":"Foundation of pharmaceutical production facility laid in Pirallahi Industrial Park [PHOTOS] - AzerNews","headline":"Foundation of pharmaceutical production facility laid in Pirallahi Industrial Park [PHOTOS]","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}